Skip to content
10-Q

Quarterly Report

Pharma-Bio Serv, Inc. PBSV

0001654954-25-007009

← back to feed
Filed
Jun 16, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jun 10, 2025 22.93M sh
Current Liabilities Q2 2025 · Apr 30, 2025 $1.78M
Current Liabilities Q2 2025 · Oct 31, 2024 $1.89M
Total Liabilities Q2 2025 · Apr 30, 2025 $1.78M
Total Liabilities Q2 2025 · Oct 31, 2024 $2.58M
Current Assets Q2 2025 · Apr 30, 2025 $13.42M
Current Assets Q2 2025 · Oct 31, 2024 $15.7M
Total Assets Q2 2025 · Apr 30, 2025 $13.9M
Total Assets Q2 2025 · Oct 31, 2024 $16.29M
Shares Diluted Q2 2025 · Apr 30, 2024 22.97M sh
Shares Diluted Q2 2025 · Apr 30, 2024 22.98M sh
Stock Repurchased Q2 2025 · Apr 30, 2024 $2.32K
Stock Repurchased Q2 2025 · Apr 30, 2024 $9.52K
Dividends Paid Q2 2025 · Apr 30, 2024 $1.72M
Dividends Paid Q2 2025 · Apr 30, 2024 $1.72M
Capex Q2 2025 · Apr 30, 2024 $0
Capex Q2 2025 · Apr 30, 2024 $820
Operating Cash Flow Q2 2025 · Apr 30, 2024 −$700.74K
Operating Cash Flow Q2 2025 · Apr 30, 2024 $25.2K
Stockholders Equity Q2 2025 · Apr 30, 2024 $13.95M
Stockholders Equity Q2 2025 · Jan 31, 2024 $14.16M
Stockholders Equity Q2 2025 · Oct 31, 2023 $16.13M
Eps Diluted Q2 2025 · Apr 30, 2024 −$0.01
Eps Diluted Q2 2025 · Apr 30, 2024 −$0.02
Sga Expense Q2 2025 · Apr 30, 2024 $931.85K
Sga Expense Q2 2025 · Apr 30, 2024 $1.91M
Net Income Q2 2025 · Apr 30, 2024 −$213.82K
Net Income Q2 2025 · Apr 30, 2024 −$484.54K
Operating Income Q2 2025 · Apr 30, 2024 −$313.38K
Operating Income Q2 2025 · Apr 30, 2024 −$751.68K
Gross Profit Q2 2025 · Apr 30, 2024 $618.48K
Gross Profit Q2 2025 · Apr 30, 2024 $1.15M
Cost Of Revenue Q2 2025 · Apr 30, 2024 $1.76M
Cost Of Revenue Q2 2025 · Apr 30, 2024 $3.6M
Revenue Q2 2025 · Apr 30, 2024 $2.38M
Revenue Q2 2025 · Apr 30, 2024 $4.76M